Ignite Creation Date:
2024-05-05 @ 11:36 PM
Last Modification Date:
2024-10-26 @ 10:35 AM
Study NCT ID:
NCT01360255
Status:
COMPLETED
Last Update Posted:
2018-10-11
First Post:
2011-05-09
Brief Title:
AFP- L3 and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma HCC Treated With Transarterial Chemoembolisation TACE
Sponsor:
Organization:
University Hospital Freiburg
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
measurement of tumor markers AFP AFP-L3 and DCP in serum samples
Enrollment Count:
70
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 14670 |
Who Masked List: